ZACROS Japan
VC Fund
Tokyo, Japan
ZACROS Japan is a healthcare company that offers optoelectronics services.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries ZACROS Japan invests in
Stages ZACROS Japan invests in
Countries ZACROS Japan invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
4 more contacts available
Investment Focus
Industry
- Health Care 3 (100%)
- Medical Device 2 (67%)
- Biotechnology 1 (33%)
- Machine Learning 1 (33%)
- Health Diagnostics 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Taku Shimoda
Executive Officer, Marketing & Business Planning Dept.; President & CEO
|
Executive Officer, Marketing & Business Planning Dept.; President & CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Revorf analyzes data and develops AI-related to infectious diseases and healthcare. | $42.1M / Venture - Series Unknown / Aug 26, 2024 | |
|
|
MiCAN Technologies medical and nursing Care company we will provide the enabling tools to eliminate Malaria and other infectious diseases by the use of pluripotent stem cell. MiCAN Technologies through the provision of “blood cell-like cell products” produced using regenerative medicine technology,They will help you research malaria and otherinfectious and immune system diseases. | $1.4M / Venture - Series Unknown / Aug 07, 2023 | |
|
|
Cyfuse Biomedical develops tissue fabrication systems and cell-based products in Japan and internationally. The company offers 3D BioFabrication systems and related consumables; develops and licenses 3D tissue products for therapeutic and drug development use; and engages in contract manufacturing of 3D tissue products for research purposes.Itsproducts applications include blood vessel grafts for blood access of hemodialysis patients or coronary artery bypass grafts; cardiac grafts for drug toxicology screening or supplemental therapy of myocardial infarction; cartilage grafts for plastic surgery or reconstruction; and hepatocyte grafts for drug metabolism screening or in-vivo production of clotting factors in the treatment of hemophilia.Cyfuse Biomedical was founded in 2010 and is based in Tokyo, Japan. | Venture - Series Unknown / Jan 29, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does ZACROS Japan invest in?
ZACROS Japan invests primarily in Health Care, Medical Device and Biotechnology startups, most often at Venture - Series Unknown stage. Most of the 3 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact ZACROS Japan?
Public channels for ZACROS Japan include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at ZACROS Japan?
The team at ZACROS Japan includes Taku Shimoda (Executive Officer, Marketing & Business Planning Dept.; President & CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!